• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗能力的增长与人口和疾病流行率的关系。

Growth in percutaneous coronary intervention capacity relative to population and disease prevalence.

机构信息

University of Texas Health Sciences Center, Houston, TX.

出版信息

J Am Heart Assoc. 2013 Oct 28;2(6):e000370. doi: 10.1161/JAHA.113.000370.

DOI:10.1161/JAHA.113.000370
PMID:24166491
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3886741/
Abstract

BACKGROUND

The access to and growth of percutaneous coronary intervention (PCI) has not been fully explored with regard to geographic equity and need. Economic factors and timely access to primary PCI provide the impetus for growth in PCI centers, and this is balanced by volume standards and the benefits of regionalized care.

METHODS AND RESULTS

Geospatial and statistical analyses were used to model capacity, growth, and access of PCI hospitals relative to population density and myocardial infarction (MI) prevalence at the state level. Longitudinal data were obtained for 2003-2011 from the American Hospital Association, the U.S. Census, and the Centers for Disease Control and Prevention (CDC) with geographical modeling to map PCI locations. The number of PCI centers has grown 21.2% over the last 8 years, with 39% of all hospitals having interventional cardiology capabilities. During the same time, the US population has grown 8.3%, from 217 million to 235 million, and MI prevalence rates have decreased from 4.0% to 3.7%. The most densely concentrated states have a ratio of 8.1 to 12.1 PCI facilities per million of population with significant variability in both MI prevalence and average distance between PCI facilities.

CONCLUSIONS

Over the last decade, the growth rate for PCI centers is 1.5× that of the population growth, while MI prevalence is decreasing. This has created geographic imbalances and access barriers with excess PCI centers relative to need in some regions and inadequate access in others.

摘要

背景

关于经皮冠状动脉介入治疗(PCI)的获取和发展,在地理公平性和需求方面尚未得到充分探讨。经济因素和及时进行直接经皮冠状动脉介入治疗为 PCI 中心的发展提供了动力,而这与容量标准和区域化护理的效益相平衡。

方法和结果

利用地理空间和统计分析,对各州 PCI 医院的容量、增长和获取情况进行建模,以评估其与人口密度和心肌梗死(MI)患病率的关系。从美国医院协会、美国人口普查局和疾病控制与预防中心(CDC)获取了 2003 年至 2011 年的纵向数据,并进行了地理建模以绘制 PCI 地点。过去 8 年来,PCI 中心的数量增长了 21.2%,有 39%的医院具备介入心脏病学能力。在此期间,美国人口增长了 8.3%,从 2.17 亿增长到 2.35 亿,而 MI 患病率从 4.0%下降到 3.7%。人口最密集的州每百万人口拥有 8.1 至 12.1 个 PCI 设施,MI 患病率和 PCI 设施之间的平均距离都存在显著差异。

结论

在过去十年中,PCI 中心的增长率是人口增长率的 1.5 倍,而 MI 患病率正在下降。这导致了地理不平衡和获取障碍,一些地区 PCI 中心过多,而另一些地区则无法获得足够的服务。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae58/3886741/327affe2b412/jah3-2-e000370-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae58/3886741/75071c863af3/jah3-2-e000370-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae58/3886741/f80e92c70c80/jah3-2-e000370-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae58/3886741/327affe2b412/jah3-2-e000370-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae58/3886741/75071c863af3/jah3-2-e000370-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae58/3886741/f80e92c70c80/jah3-2-e000370-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae58/3886741/327affe2b412/jah3-2-e000370-g3.jpg

相似文献

1
Growth in percutaneous coronary intervention capacity relative to population and disease prevalence.经皮冠状动脉介入治疗能力的增长与人口和疾病流行率的关系。
J Am Heart Assoc. 2013 Oct 28;2(6):e000370. doi: 10.1161/JAHA.113.000370.
2
Evidence of systematic duplication by new percutaneous coronary intervention programs.新型经皮冠状动脉介入治疗项目存在系统性重复的证据。
Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):400-8. doi: 10.1161/CIRCOUTCOMES.111.000019. Epub 2013 Jul 9.
3
US growth in PCI care--less than ideal, but is the ideal less?美国经皮冠状动脉介入治疗护理的增长——不尽如人意,但理想状态是否更差呢?
J Am Heart Assoc. 2013 Nov 19;2(6):e000552. doi: 10.1161/JAHA.113.000552.
4
Treatment of Coronary Artery Disease and Acute Myocardial Infarction in Hospitals With and Without On-Site Coronary Artery Bypass Graft Surgery.有和无医院现场冠状动脉旁路移植术的医院治疗冠状动脉疾病和急性心肌梗死。
Circ Cardiovasc Interv. 2019 Jan;12(1):e007097. doi: 10.1161/CIRCINTERVENTIONS.118.007097.
5
Increasing percutaneous coronary interventions for ST-segment elevation myocardial infarction in the United States: progress and opportunity.美国经皮冠状动脉介入治疗 ST 段抬高型心肌梗死的现状:进展与机遇。
JACC Cardiovasc Interv. 2015 Jan;8(1 Pt B):139-146. doi: 10.1016/j.jcin.2014.07.017. Epub 2014 Oct 30.
6
Impact of Patient Distance From Percutaneous Coronary Intervention Centers on Longitudinal Outcomes.患者与经皮冠状动脉介入治疗中心的距离对长期预后的影响。
Circ Cardiovasc Qual Outcomes. 2018 Sep;11(9):e004623. doi: 10.1161/CIRCOUTCOMES.118.004623.
7
Rural Patient Access to Primary Percutaneous Coronary Intervention Centers is Improved by a Novel Integrated Telemedicine Prehospital System.一种新型综合远程医疗院前系统改善了农村患者对初级经皮冠状动脉介入治疗中心的就医机会。
J Emerg Med. 2015 Nov;49(5):657-64. doi: 10.1016/j.jemermed.2015.05.009. Epub 2015 Jul 26.
8
Nationwide Analysis of Patients With ST-Segment-Elevation Myocardial Infarction Transferred for Primary Percutaneous Intervention: Findings From the American Heart Association Mission: Lifeline Program.ST段抬高型心肌梗死患者转至行直接经皮冠状动脉介入治疗的全国性分析:美国心脏协会“使命:生命线”项目的研究结果
Circ Cardiovasc Interv. 2015 May;8(5). doi: 10.1161/CIRCINTERVENTIONS.114.002450.
9
Government Regulation and Percutaneous Coronary Intervention Volume, Access and Outcomes: Insights From the Washington State Cardiac Care Outcomes Assessment Program.政府监管与经皮冠状动脉介入治疗量、可及性和结局:来自华盛顿州心脏护理结局评估计划的见解。
J Am Heart Assoc. 2022 Sep 6;11(17):e025607. doi: 10.1161/JAHA.122.025607. Epub 2022 Sep 3.
10
Primary percutaneous coronary intervention expansion to hospitals without on-site cardiac surgery in Michigan: a geographic information systems analysis.密歇根州将直接经皮冠状动脉介入治疗扩展至无现场心脏手术的医院:一项地理信息系统分析
Am Heart J. 2008 Apr;155(4):668-72. doi: 10.1016/j.ahj.2007.10.051. Epub 2008 Mar 7.

引用本文的文献

1
Geospatial Access to Extracorporeal Membrane Oxygenation in the United States.美国体外膜肺氧合治疗的地理空间可及性
Crit Care Med. 2025 Feb 17;53(4):e874-83. doi: 10.1097/CCM.0000000000006607.
2
Tenecteplase vs Reteplase in Patients with Acute ST-Elevation Myocardial Infarction: A Retrospective Cohort Study.替奈普酶与瑞替普酶治疗急性ST段抬高型心肌梗死患者的回顾性队列研究
Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296251316876. doi: 10.1177/10760296251316876.
3
Advancing Health Equity in the Cardiovascular Device Life Cycle.

本文引用的文献

1
Evidence of systematic duplication by new percutaneous coronary intervention programs.新型经皮冠状动脉介入治疗项目存在系统性重复的证据。
Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):400-8. doi: 10.1161/CIRCOUTCOMES.111.000019. Epub 2013 Jul 9.
2
ACCF/AHA/SCAI 2013 update of the clinical competence statement on coronary artery interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (writing committee to revise the 2007 clinical competence statement on cardiac interventional procedures).ACCF/AHA/SCAI 2013年冠状动脉介入手术临床能力声明更新:美国心脏病学会基金会/美国心脏协会/美国内科医师学会临床能力与培训特别工作组(修订2007年心脏介入手术临床能力声明的写作委员会)报告
Circulation. 2013 Jul 23;128(4):436-72. doi: 10.1161/CIR.0b013e318299cd8a. Epub 2013 May 8.
3
在心血管器械生命周期中推进健康公平。
Circ Cardiovasc Qual Outcomes. 2025 Mar;18(3):e011310. doi: 10.1161/CIRCOUTCOMES.124.011310. Epub 2025 Feb 3.
4
Is more better? A multilevel analysis of percutaneous coronary intervention hospital openings and closures on patient volumes.更多更好吗?经皮冠状动脉介入治疗医院开放和关闭对患者量的多层次分析。
Acad Emerg Med. 2024 Oct;31(10):994-1005. doi: 10.1111/acem.14926. Epub 2024 May 16.
5
The impact of regional STEMI systems on protocol use and quality improvement initiatives in community hospitals without cardiac catheterization laboratories.区域ST段抬高型心肌梗死(STEMI)系统对没有心脏导管实验室的社区医院中方案使用和质量改进举措的影响。
Am Heart J Plus. 2021 Dec 9;13:100077. doi: 10.1016/j.ahjo.2021.100077. eCollection 2022 Jan.
6
Interfacility Transfer of Uninsured vs Insured Patients With ST-Segment Elevation Myocardial Infarction in California.加利福尼亚州无保险与有保险 ST 段抬高型心肌梗死患者的医疗机构间转运。
JAMA Netw Open. 2023 Jun 1;6(6):e2317831. doi: 10.1001/jamanetworkopen.2023.17831.
7
Trends in the likelihood of receiving percutaneous coronary intervention in a low-volume hospital and disparities by sociodemographic communities.低容量医院接受经皮冠状动脉介入治疗的可能性趋势及社会人口统计学社区的差异。
PLoS One. 2023 Jan 18;18(1):e0279905. doi: 10.1371/journal.pone.0279905. eCollection 2023.
8
Association of Admission Time and Mortality in STEMI Patients: A Systematic Review and Meta-analysis.ST段抬高型心肌梗死患者入院时间与死亡率的关联:一项系统评价和荟萃分析
Int J Angiol. 2022 Mar 3;31(4):273-283. doi: 10.1055/s-0042-1742610. eCollection 2022 Dec.
9
Government Regulation and Percutaneous Coronary Intervention Volume, Access and Outcomes: Insights From the Washington State Cardiac Care Outcomes Assessment Program.政府监管与经皮冠状动脉介入治疗量、可及性和结局:来自华盛顿州心脏护理结局评估计划的见解。
J Am Heart Assoc. 2022 Sep 6;11(17):e025607. doi: 10.1161/JAHA.122.025607. Epub 2022 Sep 3.
10
STEMI care 2021: Addressing the knowledge gaps.2021年ST段抬高型心肌梗死护理:填补知识空白
Am Heart J Plus. 2021 Nov;11:100044. doi: 10.1016/j.ahjo.2021.100044. Epub 2021 Aug 25.
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会基金会/美国心脏协会ST段抬高型心肌梗死管理指南:执行摘要:美国心脏病学会基金会/美国心脏协会实践指南工作组报告
Circulation. 2013 Jan 29;127(4):529-55. doi: 10.1161/CIR.0b013e3182742c84. Epub 2012 Dec 17.
4
Contemporary evidence about hospital strategies for reducing 30-day readmissions: a national study.关于医院降低 30 天再入院率策略的当代证据:一项全国性研究。
J Am Coll Cardiol. 2012 Aug 14;60(7):607-14. doi: 10.1016/j.jacc.2012.03.067. Epub 2012 Jul 18.
5
Expansion of a regional ST-segment-elevation myocardial infarction system to an entire state.将区域性 ST 段抬高型心肌梗死系统扩展到整个州。
Circulation. 2012 Jul 10;126(2):189-95. doi: 10.1161/CIRCULATIONAHA.111.068049. Epub 2012 Jun 4.
6
Has the time come for a national cardiovascular emergency care system?
Circulation. 2012 Apr 24;125(16):2035-44. doi: 10.1161/CIRCULATIONAHA.111.084509.
7
Application of geographic modeling techniques to quantify spatial access to health services before and after an acute cardiac event: the Cardiac Accessibility and Remoteness Index for Australia (ARIA) project.地理建模技术在急性心脏事件前后量化卫生服务空间可达性中的应用:澳大利亚心脏可达性和偏远指数(ARIA)项目。
Circulation. 2012 Apr 24;125(16):2006-14. doi: 10.1161/CIRCULATIONAHA.111.083394. Epub 2012 Mar 26.
8
A percutaneous coronary intervention lab in every hospital?每家医院都配备一个经皮冠状动脉介入治疗实验室?
Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):14-20. doi: 10.1161/CIRCOUTCOMES.111.963868. Epub 2011 Dec 6.
9
Door-to-balloon times under 90 min can be routinely achieved for patients transferred for ST-segment elevation myocardial infarction percutaneous coronary intervention in a rural setting.对于因 ST 段抬高型心肌梗死行经皮冠状动脉介入治疗而转院的患者,在农村地区可常规实现 90 分钟内门球时间达标。
J Am Coll Cardiol. 2011 Jan 18;57(3):272-9. doi: 10.1016/j.jacc.2010.06.056.
10
Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI.ST段抬高型心肌梗死和非 ST 段抬高型心肌梗死患者的发病率、治疗和结局的最新趋势。
Am J Med. 2011 Jan;124(1):40-7. doi: 10.1016/j.amjmed.2010.07.023.